Pfizer is having a tough time selling its consumer health care business
March 23, 2018 at 14:08 PM EDT
GlaxoSmithKline, Reckitt Benckiser and Johnson & Johnson have each decided not to pursue a deal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.